Journal
DRUG DISCOVERY TODAY
Volume 13, Issue 21-22, Pages 917-931Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2008.06.008
Keywords
-
Categories
Ask authors/readers for more resources
Since the demonstration of RNA interference (RNAi) in mammalian cells, considerable research and financial effort has gone towards implementing RNAi as a viable therapeutic platform. RNAi is, without doubt, the most promising strategy for the treatment of human genetic disorders. Because many of the targets proposed for RNAi therapy require chronic treatment, researchers agree that the emphasis must now be placed on the safe and long-term application of RNAi drugs to reap the benefits at last.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available